2011
DOI: 10.1016/j.bmcl.2011.02.096
|View full text |Cite
|
Sign up to set email alerts
|

The discovery of novel 8-azabicyclo[3.2.1]octan-3-yl)-3-(4-chlorophenyl) propanamides as vasopressin V1A receptor antagonists

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2011
2011
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 8 publications
0
2
0
Order By: Relevance
“…[29,30] The azabicyclo[3.2.1]octane moiety composes the core structure of various biologically active compounds with antiproliferative, antimicrobial, analgesic, and antiinflammatory effects that are occasionally exploited as drugs. [31][32][33][34][35][36] In 1909, cocaine (COC) (Figure 1a), a natural product containing azabicyclo[3.2.1]octane that is extracted from the leaves of the coca bush (Erythroxylum coca) plant, [37] was reported as an anticancer drug by Gilchrist. [38] Research in this regard has led to the recent development of different binary [39,40] and heteroleptic [41] metal complexes of COC exhibiting anticancer activity.…”
Section: Introductionmentioning
confidence: 99%
“…[29,30] The azabicyclo[3.2.1]octane moiety composes the core structure of various biologically active compounds with antiproliferative, antimicrobial, analgesic, and antiinflammatory effects that are occasionally exploited as drugs. [31][32][33][34][35][36] In 1909, cocaine (COC) (Figure 1a), a natural product containing azabicyclo[3.2.1]octane that is extracted from the leaves of the coca bush (Erythroxylum coca) plant, [37] was reported as an anticancer drug by Gilchrist. [38] Research in this regard has led to the recent development of different binary [39,40] and heteroleptic [41] metal complexes of COC exhibiting anticancer activity.…”
Section: Introductionmentioning
confidence: 99%
“…At a preclinical stage, Johnson and Johnson demonstrated the in vivo efficacy of 5 (JNJ-17308616) in a rat model of anxiety . More recently, MSD disclosed a novel series of CNS penetrant V1a antagonists exemplified by 6 with a good affinity for the rat receptor . Peripheral in vivo functional V1a antagonism was demonstrated by the reversal of V1a mediated arginine vasopressin (AVP) induced blood pressure increases in conscious rats.…”
Section: Introductionmentioning
confidence: 99%